These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12630081)

  • 21. [Functional activity of human thyrocytes in diffuse toxic goiter, autoimmune thyroiditis and thyroid nodules using nucleolar silver staining].
    Mamaev NN; Grineva EN; Laevskaia ND; Blagosklonnaia IaV
    Arkh Patol; 1994; 56(2):58-62. PubMed ID: 8037597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid cancer in patients with toxic nodular goiter--is the incidence increasing?
    Choong KC; McHenry CR
    Am J Surg; 2015 Jun; 209(6):974-6. PubMed ID: 25896315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
    Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic multinodular goiter in the elderly.
    Vitti P; Rago T; Tonacchera M; Pinchera A
    J Endocrinol Invest; 2002; 25(10 Suppl):16-8. PubMed ID: 12508907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reliability of the fine needle aspiration puncture in non-toxic nodular goiter. Correlation with surgical findings and repeated punctures].
    Astorga R; García-Cantón JA; Rodríguez JR; Leal A; Acosta D; Gavilán I; García-Luna PP; León J
    Med Clin (Barc); 1985 Nov; 85(18):733-6. PubMed ID: 4094484
    [No Abstract]   [Full Text] [Related]  

  • 26. Fine needle aspiration cytology in non-neoplastic non-toxic recurrent nodular goitre.
    Słowińska-Klencka D; Klencki M; Sporny S; Lewiński A
    Cytopathology; 2003 Aug; 14(4):216-20. PubMed ID: 12873316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC).
    Nassar A; Gupta P; LiVolsi VA; Baloch Z
    Diagn Cytopathol; 2003 Nov; 29(5):243-5. PubMed ID: 14595788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical therapeutic planning options in nodular goiter.
    Pelizzo MR; Merante Boschin I; Toniato A; Sorgato N; Marzola MC; Rubello D
    Minerva Endocrinol; 2010 Sep; 35(3):173-85. PubMed ID: 20938420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperthyroidism and carcinoma of the thyroid gland].
    Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
    Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cytokines in thyrotoxicosis.
    Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nodular hyperthyroidism: surgical experience and hypothesis of carcinogenic correlations].
    Vetere F; Marlia E; Cucchi MC
    G Chir; 1989 Jun; 10(6):325-9. PubMed ID: 2518428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the impact of short-term Lugol's solution on toxic nodular thyroid disease: a pre-post-intervention study.
    Hedberg F; Cramon PK; Bränström R; Falhammar H; Calissendorff J
    Front Endocrinol (Lausanne); 2024; 15():1420154. PubMed ID: 39119004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
    Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
    Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clear nuclei are specific to papillary carcinoma in thyroid fine-needle aspirates processed by Ultrafast Papanicolaou stain.
    Yang GC
    Diagn Cytopathol; 2003 Oct; 29(4):236-7; author reply 238. PubMed ID: 14506680
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features.
    Layfield LJ; Wax T; Jones C
    Cancer; 2003 Aug; 99(4):217-22. PubMed ID: 12925983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodular goiter: a histo-cytological study with some emphasis on pitfalls of fine-needle aspiration cytology.
    Harach HR; Zusman SB; Saravia Day E
    Diagn Cytopathol; 1992; 8(4):409-19. PubMed ID: 1638942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thyrostatic therapy of hyperthyroidism with special reference to drug side effects].
    Heberling HJ; Lohmann D
    Z Gesamte Inn Med; 1983 Dec; 38(24):660-3. PubMed ID: 6199908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of non-toxic goitre.
    Wang KW; Sum CF; Tan KT; Ng WY; Cheah JS
    Ann Acad Med Singap; 1990 Jul; 19(4):439-42. PubMed ID: 2221798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nodular toxic goiter in children: clinical features, morphological variants].
    Ivannikova TE; Bezlepkina OB; Abdulhabirova FM; Abrosimov AU; Degtyarev MV; Zubkova NA
    Probl Endokrinol (Mosk); 2021 Apr; 67(2):102-110. PubMed ID: 34004107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The electrocardiogram in the treatment of toxic goiter patients with thyrostatic drugs].
    Greĭser AE; Fomin LM
    Klin Med (Mosk); 1972 Aug; 50(8):95-8. PubMed ID: 4121933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.